Comparative Effect of Training on Postpartum Depression

Sponsor
Riphah International University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05891717
Collaborator
(none)
36
1
2
8.3
4.3

Study Details

Study Description

Brief Summary

New mothers experience postpartum depression after childbirth, which commonly include mood swings, crying spells, anxiety and difficulty sleeping. Resistance training (RT) is one of the most popular methods of exercise for improving physical fitness.

This study will be a randomized clinical trial. It divide into two groups. Data will be collected from Jinnah Hospital Lahore, Family Health hospital, Johar town. Data will be taken from 36 postpartum females. Participants will be divided into 2 groups 18 women in each group: 1st group will be treated with resistance training group and 2nd group will be active comparison flexibility training group. In this study Exercises self-efficacy scale, Epidemiological studies Depression scale and MAPP-QOL (Maternal Postpartum Quality Life Questionnaire) will be used as subjective measurements.

Condition or Disease Intervention/Treatment Phase
  • Other: Resistance training
  • Other: Flexibility training
N/A

Detailed Description

New mothers experience postpartum depression after childbirth, which commonly include mood swings, crying spells, anxiety and difficulty sleeping. Postpartum depression typically begins within the first two to three days after delivery and may last for up to several weeks or months. Activity and mobility are an integral part of human life that is manifested in a special way in each period. Postpartum life has caused lack of movement, the risk factor of depression and difficulty in maternal life. Resistance training (RT) is one of the most popular methods of exercise for improving physical fitness. A logical approach to treatment, therefore, would be to improve postpartum life. Flexibility exercises are not just for gymnasts, but rather for everyone. Along with the better range of motion, it decreases risks of injuries, increases blood supply and nutrients to joints, reduces muscular tension and help to improve quality of life.

This study will be a randomized clinical trial. Subjects meeting the predetermined inclusion and exclusion criteria will divide into two groups. Data will be collected from Jinnah Hospital Lahore, Family Health hospital, Johar town. After informed consents were obtained, data will collect. After taking written consent from participants who meet the inclusion criteria, data will be taken from 36 postpartum females. Participants will be divided into 2 groups 18 women in each group: 1st group will be treated with resistance training group and 2nd group will be active comparison flexibility training group. Pre-treatment assessment and Post treatment reading will be done using Exercises self-efficacy scale, Epidemiological studies Depression scale and MAPP-QOL (Maternal Postpartum Quality Life Questionnaire) as subjective measurements. Recorded values will be analyzed for any change using SPSs version 25.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Comparative Effect of Flexibility and Resistance Training on Self-efficacy, Symptoms and Maternal Quality of Life in Postpartum Depression
Actual Study Start Date :
Nov 20, 2022
Anticipated Primary Completion Date :
Jul 13, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Resistance training

Group A will receive resistance training. Twice per week for 8 weeks. Total 16 sessions will given.

Other: Resistance training
Twice per week for 8 weeks. Total 16 sessions will given.

Active Comparator: Flexibility training

Group B will receive flexibility training. Twice per week for 8 weeks. Total 16 sessions will given.

Other: Flexibility training
Twice per week for 8 weeks. Total 16 sessions will given.

Outcome Measures

Primary Outcome Measures

  1. Exercise self efficacy [8 weeks]

    A 9-item questionnaire that focuses on the self-efficacy expectations for exercise for older adults; specifically the ability to continue to exercise despite barriers. The participant is asked about their confidence level, on a scale from 0 (not confident) to 10 (very confident)

  2. Epidemiological studies Depression scale [8 weeks]

    The Center for Epidemiologic Studies Depression Scale (CES-D) is a brief self-report questionnaire developed in 1977 by Laurie Radloff to measure depressive symptoms severity in the general population

  3. MAPP-QOL ( Maternal Postpartum Quality Life Questionnaire) [8 weeks]

    Maternal Postpartum Quality of Life (MAPP-QOL) questionnaire, which is a self-administered instrument that measures quality of life during the early postnatal period. 12 The MAPP-QOL is composed of five domains and demonstrates convergent validity with measures of life satisfaction and mood states.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 20 to 40

  • 6 weeks to 8 months postpartum females

  • primiparous or multiparous postnatal wome

Exclusion Criteria:
  • Family history of depression

  • Hospitalization for a psychiatric disorder in the past 6 months; and currently receiving antidepressant medication or psychotherapy for depression.

  • Pregnant women

  • Women with psychiatric diagnoses other than depression

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jinnah Hospital Lahore Punjab Pakistan 54000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Sabiha Arshad, M.Phill, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05891717
Other Study ID Numbers:
  • REC/RCR & AHS/23/0509
First Posted:
Jun 7, 2023
Last Update Posted:
Jun 7, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Riphah International University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 7, 2023